SYTL2, synaptotagmin like 2, 54843

N. diseases: 58; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.020 Biomarker disease BEFREE Loss of SLP2 drastically suppressed the proliferation of GC cells and inhibited the tumor growth, while SLP2 overexpression promoted the progression of GC. 30555578 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.020 AlteredExpression disease BEFREE Overexpression of SLP-2 may contribute to the progression and poor prognosis of GC. 23371255 2013